ロード中...

Type 2 diabetes, thiazolidinediones, and cardiovascular risk

Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achieving adequate glycaemic control is an important aim of therapy. Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone and pioglitazone are currently...

詳細記述

保存先:
書誌詳細
主要な著者: Taylor, Clare, Hobbs, FD Richard
フォーマット: Artigo
言語:Inglês
出版事項: Royal College of General Practitioners 2009
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2702020/
https://ncbi.nlm.nih.gov/pubmed/19567003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3399/bjgp09X453440
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!